Two of AstraZeneca’s top cancer treatments have been approved in combination to treat a subgroup of endometrial cancer patients in the European Union, the drugmaker …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week
Acoramidis (Attruby) gained FDA approval for treating wild-type or variant transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM), BridgeBio Pharma announced. Offering patients near-complete TTR stabilization in an
The FDA is preparing to release “systemic” changes to its advisory committee process, Commissioner Rob Califf said Wednesday, building on months of hints that a